Join to View Full Profile
9200 W Wisconsin AveMilwaukee, WI 53226
Phone+1 414-805-0505
Fax+1 414-955-0231
Dr. Saber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2006 - 2009
Cleveland Clinic FoundationResidency, Internal Medicine, 1998 - 2001
Ain Shams University Faculty of MedicineClass of 1995
Certifications & Licensure
WI State Medical License 2006 - 2027
OH State Medical License 2000 - 2010
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.Andrew S Artz, Brent Logan, Wael Saber, Nancy Geller, Anna Bellach
Blood Advances. 2026-03-10 - Validated clinical risk score for acute graft-versus-host disease in adult allogeneic hematopoietic cell transplantation.Caden M Ulschmid, Xiao Li, Tao Wang, Brent R Logan, Joseph Pidala
Blood Advances. 2026-02-24 - Exposure to Agent Orange and Association with Myelodysplastic Syndromes.Mikkael A Sekeres, Amy E DeZern, Michael Otterstatter, Eric Padron, Tareq Al Baghdadi
Blood Advances. 2026-02-24
Abstracts/Posters
- Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid LeukemiaWael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea...Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Superior Survival with Post-Remission Pediatric-Inspired Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Adolescents and Young ...Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Center for International Blood & Marrow Transplant Research Celebrates 50 YearsApril 22nd, 2022
Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 9th, 2017
Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
